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Abstract 
Background and Aim. Recent studies disclosed that autophagy facilitates the process of 
senescence. Given cellular senescence is involved in the pathophysiology of ductular reaction 
(DR) in primary biliary cirrhosis (PBC), we examined an involvement of autophagy in DRs in 
PBC and control livers. Methods. We examined immunohistochemically the expression of 
microtubule-associated proteins-light chain 3 (LC3) as autophagy marker, 
p62/sequestosome-1 (p62) as autophagy-related marker in bile ductular cells in livers taken 
from the patients with PBC (n=42) and control livers (n=100). The expression of senescent 
markers (p16INK4a and p21WAF1/Cip1) in bile ductular cells and their correlation with autophagy 
was also evaluated. Results. The expression of LC3 was seen in coarse vesicles in cytoplasm 
of bile ductular cells and significantly more frequent in PBC of both early and advanced 
stages, when compared with control livers (p<0.01). The expression of p62 was seen as 
intracytoplasmic aggregates and significantly more frequent in PBC, when compared with 
control livers (p<0.05). The expression of LC3 and p62 significantly correlated each other 
(p<0.01). The expression of LC3 and p62 significantly correlated with the expression of 
p16INK4a, p21WAF1/Cip1 (p<0.05). Conclusion. Autophagy is frequently seen in bile ductular 
cells in DRs in PBC. Since cellular senescence of bile ductular cells is rather frequent in the 
advanced stage of PBC, autophagy may precede cellular senescence of bile ductular cells in 
DRs in PBC. 
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Introduction 
Ductular reaction (DR) is a reactive lesion at the portal tract interface comprising increased 
bile ductules with an accompanying complex of stromal and inflammatory cells (1). The 
involvement of DR has been implicated in the pathogenesis of progressive fibrosis, 
regeneration and hepatocarcinogenesis in chronic liver disease (1-3). We have recently 
reported that bile ductular cells undergoing cellular senescence, which are characterized by 
the augmented expression of senescence-associated -galactosidase (SA--gal), p16INK4a and 
p21WAF1/Cip and telomere shortening, increase in PBC along with fibrous progression, 
especially in PBC (4-6). Cellular senescence is a state of stable cell arrest with active 
metabolism and a failsafe program against a variety of cellular insults. Cellular senescence is 
a delayed stress response involving multiple effector mechanisms such as the DNA damage 
response (7) and the senescence-associated secretion phenotype (SASP)(8-11). Such 
senescent bile ductular cells may be involved in the progression of fibrosis of these diseases, 
through the secretion of SASP (4-6, 11).  
Autophagy (hereafter referred to as autophagy) in human diseases has been 
highlighted during the last decade (12-14) and recent data demonstrated that autophagy is 
significantly involved in the pathophysiology of liver diseases (15-21). Macroautophagy is a 
genetically regulated program responsible for the turnover of cellular proteins and damaged 
organelles. This evolutionarily conserved process is characterized by the formation of double 
membrane cytosolic vesicles, autophagosomes, which sequester cytoplasmic content and 
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deliver it to lysosomes (12, 13, 22, 23). Autophagy can enable adaptation to stress through the 
degradation of cellular proteins and organelles to suppress damage, maintain metabolism, and 
promote cellular viability and fitness (12-14, 23). An appropriate cellular stress response is 
critical for maintaining tissue integrity and function and for preventing diseases. Cells 
respond to stress with adaptation, repair, and recovery, or are diverted into irreversible cell 
cycle exit (senescence) or are eliminated through programmed cell death (apoptosis)(23). 
Dysfunctional autophagy appears to be associated with cellular senescence (23).  
Autophagy and cellular senescence are two distinct cellular responses to stress. 
Recent studies disclosed that autophagy facilitates the process of senescence (22). We have 
also reported that autophagy may precedes biliary epithelial senescence in the damaged bile 
ducts in primary biliary cirrhosis (PBC)(20). Although cellular senescence is involved in the 
pathophysiology of DR along with fibrous progression in primary biliary cirrhosis (PBC) 
(4-6), there has been no study reporting the involvement of autophagy in ductular cells in PD. 
In the present study, we examined an involvement of autophagy and its association with 
cellular senescence in DRs in PBC and control livers.  
 
Materials and Methods 
Classification of intrahepatic biliary tree. The intrahepatic biliary tree is classified into the 
intrahepatic large and small bile ducts (septal and interlobular bile ducts) by their size and 
distributions in the portal tracts (24). In this study, septal and interlobular bile ducts are 
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termed small bile ducts. Bile ductules are not included in the small bile ducts. Bile ductules 
are characterized by tubular or glandular structures with poorly defined lumen and located at 
the periphery of the portal tracts and are not accompanied by parallel running hepatic arterial 
branches (1, 24). Ductular cells in ductular reaction (1) including intermediate hepatobiliary 
cells with heterogeneous phenotype in the diseased liver were also evaluated 
Liver tissue preparation. A total of 142 liver tissue specimens (all were biopsied or 
surgically-resected) were collected from the liver disease file of our laboratory and affiliated 
hospitals. The liver specimens enrolled in this study were 42 PBC, 41 chronic viral hepatitis 
(CVH) livers, 27 nonalcoholic steatohepatitis (NASH), 10 extrahepatic biliary obstruction 
(EBO) livers and 22 “histologically normal” livers. All PBC were from the patients fulfilling 
the clinical, serological and histological characteristics consistent with the diagnosis of PBC 
(25). PBC livers were staged histologically (26) and 29 and 13 of PBC were of stages 1, 2 
(early PBC) and of stages 3, 4 (advanced PBC), respectively. Twenty-seven CVH were 
regarded as F0-2 and 14 as F3, 4, respectively (27). Three and 38 of CVH cases were 
serologically positive for hepatitis B surface antigen (HBsAg) and anti-hepatitis C viral 
antibody (HCVAb), respectively. The grade of activity and stage in the patients with NASH 
were assessed by using the criteria proposed by Brunt et al. (28), and 14 and 13 NASH were 
regarded as stages 1, 2 and stages 3, 4, respectively. Causes of EBO were obstruction of the 
bile duct at the hepatic hilum or the extrahepatic bile ducts, because of carcinoma or stone, 
and the duration of jaundice was less than 1 month. “Histologically normal” livers were 
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obtained from surgically resected livers for traumatic hepatic rupture or metastatic liver tumor. 
The liver tissues used were taken from the part sufficiently away from the trauma and tumor.  
Liver tissue samples were fixed in 10% neutral buffered formalin, and embedded in 
paraffin. More than twenty serial sections, 4 μm thick, were cut from each block. Several 
were processed routinely for histopathologic study, and the remainder was processed for the 
following immunohistochemistry. The Committee of Ethics in Kanazawa University approved 
this study.  
Immunohistochemistry. We examined immunohistochemically the expression of 
microtubule-associated proteins-light chain 3 (LC3) as an autophagy marker, 
p62/sequestosome-1 (p62)(29, 30) as an autophagy-related marker in bile ductular cells. The 
expression of senescent markers (p16INK4a and p21WAF1/Cip1) in bile ductular cells and their 
correlation with autophagy was also examined in same sample series. Immunostaining was 
performed using the antibodies shown in Table 1, as described previously (31). In brief, after 
pretreatment for antigen retrieval as described in Table 1, blocking endogenous peroxidase, 
the sections were incubated with the primary antibody at 4 degree overnight. The Envision+ 
solution (Dako) was then applied for 30 min at room temperature.  The reaction products 
were visualized using 3-3’-diaminobenizidine tetra hydrochloride (Sigma Chemica, Co., St. 
Louis, MO) and H2O2. The sections were then lightly counterstained with methyl green or 
hematoxylin. A similar dilution of the control mouse IgG (Dako) was applied instead of the 
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primary antibody as negative control.  Positive and negative controls were routinely 
included.  
Assessment of immunostaining. All fields of each liver specimen were observed under light 
microscope for the evaluation of immunohistochemical expression of LC3, p62, p16INK4a and 
p21WAF1/Cip1. The extent of expression was semiquantitatively evaluated as 1+ (focal, positive 
cells are detected in one third or fewer portal tracts), and 2+ (extensive, positive cells are 
detected in more than one third of portal tracts). 
 
Statistical analysis. Statistical analysis for the difference used the Wilcoxon rank sum test. 
The correlation coefficient of 2 factors was evaluated using Spearman’s rank correlation test. 
When the P value was less than 0.05, the difference was regarded as significant.   
 
Results 
LC3. The expression of LC3 was seen in coarse vesicles in the cytoplasm of bile ductular 
cells, when detectable (Fig.1A). As shown in Figure 2A, the expression of LC3 was more 
frequent in ductular cells in the early stages of PBC (1+, 50%; 2+, 15%) and the advanced 
stages of PBC (1+, 23%; 2+, 31%), compared to other groups; CVH, F1/2 (1+, 6.7%; 2+, 0%), 
CVH, F3/4 (1+, 18%; 2+, 0%), NASH stages 1 and 2 (1+, 0%; 2+, 0%), NASH stages 3 and 4 
(1+, 8.3%; 2+, 0%), EBO (1+, 10%; 2+, 0%) and normal livers (1+, 0%; 2+, 0%), respectively 
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(p<0.01). The expression of LC3 in CVH, F3/4 was significantly more frequent, compared to 
normal livers (p<0.05).   
p62. The expression of p62 was seen as intracytoplasmic aggregates in bile ductular cells, 
when detectable (Fig.1B). As shown in Figure 2B, the expression of p62 was more frequent in 
ductular cells in the early stages of PBC (1+, 45%; 2+, 17%) and the advanced stages of PBC 
(1+, 31%; 2+, 31v%), compared to NASH stages 1 and 2 (1+, 0%; 2+, 0%) and normal livers 
(1+, 9%; 2+, 0%), respectively (p<0.01). The expression of p62 was more frequent in the 
early and advanced stages of PBC, compared to CVH, F1/2 (1+, 33%; 2+, 0%), CVH, F3/4 
(1+, 14%; 2+, 7.1%), respectively (p<0.05).  
The correlation between expressions of LC3, p62, p16INK4a and p21WAF1/Cip1.  
The expression of LC3 and p62 (p<0.01, rs=0.38703) were significantly correlated in bile 
ductular cells (Fig.2C). The expression of p16INK4a and p21WAF1/Cip1 were significantly more 
frequent in bile ductular cells in PBC, stage 3, 4, when compared with control livers (p<0.05), 
as previously reported (5, 6). There were significant correlation between the expression of 
LC3 and p16INK4a (p<0.01, rs=0.574), the expression of LC3 and p21WAF1/Cip1 (p<0.01, 
rs=0.462), the expression of p62 and p16INK4a (p<0.01, rs=0.336), the expression of p62 and 
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Discussion 
The data obtained in this study are summarized as follows; 1) LC3, an autophagy marker, and 
p62, an autophagy-related marker, were frequently expressed in ductular cells in DR in PBC, 
compared to those in CVH, NASH, EBO and normal livers. 2) The expression of LC3 and 
p62 was significantly correlated each other in ductular cells in DR. 3) The expression of LC3 
and p62 was significantly correlated with the expression of senescent markers: p16INK4a and 
p21WAF1/Cip1 in ductular cells in DR. 
The present study firstly disclosed that ductular cells in DR frequently show 
autophagy detected by immunostaining for LC3 in PBC, whereas autophagy is infrequently 
detected in DR in control livers. This finding clearly indicates that autophagy is involved in 
the pathogenesis of DR in PBC and DR in PBC may be different from other liver disease. We 
have shown that autophagy is upregulated in the damage bile ducts in PBC (20). Therefore, 
the autophagy appears to be a common feature of biliary epithelial cells in small bile ducts 
and DR in PBC. 
Furthermore, it is of interest that the accumulation of p62 is frequently seen in DR 
in PBC, similarly to LC3. p62 is an adaptor protein involved in the delivery of 
ubiquitin-bound cargo to the autophagosome and regulates the formation of protein 
aggregates (29, 32-34). An accumulation of p62 is seen in autphagy-deficient condition, so, 
the accumulation of p62 may be a marker of dysfunctional autophagy in which the capacity of 
autophagy is not much enough to process the damaged proteins bound to p62(19, 21, 35). 
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Therefore, the accumulation of p62 may reflect dysfunctional autophagy in ductular cells in 
DR in PBC. In addition, the expression of LC3 and p62 was significantly correlated each 
other in ductular cells in DR. Taken together, autophagy, especially dysfunctional autophagy 
may be involved in the pathophysiology of ductular cells in PBC. 
Recent studies have disclosed that autophagy preceded and accelerated cellular 
senescence (22) and we have also reported that autophagy mediates biliary epithelial 
senescence (20). Our previous study shows that some of ductular cells in DR in chronic liver 
diseases were at G1- arrest and undergoing cellular senescence and that such senescent cells 
may be involved in the progression of fibrosis of these diseases, particularly in PBC (6). The 
present study revealed that the expression of autophagy markers: LC3 and p62 was 
significantly correlated with the expression of senescent markers: p16INK4a and p21WAF1/Cip1 in 
ductular cells in DR. This finding suggests that autophagy is involved in the biliary epithelial 
senescence in DR. Dysfunctional autphagy may induce cellular senescence. It is of interest 
that autophagy is upregulated in DR in both early and advanced PBC, whereas cellular 
senescence is more frequent in DR in the advanced PBC in our previous study. This may also 
support hypothesis that biliary epithelial senescence may be induced via process of autophagy. 
Taken together, the regulation of autophagy may be a therapeutic target to prevent the 
progression of fibrosis along with biliary epithelial senescence in PBC. 
In conclusion, autophagy is frequently seen and correlated with cellular senescene 
in bile ductular cells in DRs in PBC, both in the early and advanced stage. These findings 
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suggest that autophagy may be involved in the pathophysiology of DRs in PBC and may 
precede cellular senescence of bile ductular cells in DRs in PBC. Since cellular senescence of 
bile ductular cells is rather frequent in the adanced stage of PBC, autophagy may precede 
cellular senescence of bile ductular cells in DRs in PBC.  
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Figure legends 
1. Expression of LC3 and p62 in ductular reaction (DR) in PBC and control liver.  
A) Coarse vesicular expression of LC3 in DRs in PBC. Coarse vesicular expression of LC3 is 
seen in the cytoplasm of ductular cells in PBC (left, arrows), whereas no expression of LC3 is 
found in ductular cells in CVH, C (right, arrows). Immunostaining for LC3. Original 
magnification, x400. B) Coarse vesicular expression of p62 is seen in the cytoplasm of 
ductular cells in PBC (left, arrows), whereas no or faint expression of p62 is found in ductular 
cells in CVH, C (right, arrows). Immunostaining for p62. Original magnification, x400.  
 
2. Increased expression of LC3 and p62 in ductular reaction (DR) in PBC. 
A) The frequency and extent of LC3 expression. White column, focal expression (1+), 
gray columns, extensive expression (2+). a, p<0.01 vs other groups, b, p<0.05 vs normal 
liver (NL). B) The frequency and extent of p62 expression. White column, focal 
expression (1+), gray columns, extensive expression (2+). a, p<0.01 vs normal liver (NL) 
and nonalcoholic steatohepatitis (NASH), stage (st)1 and 2, b, p<0.05 vs chronic viral 
hepatitis (CVH), F1 and F2 and F3 and F4. C) Correlation between expression of LC3 
and p62 in ductular reaction (DR) in primary biliary cirrhosis (PBC) and control diseases. 
In PBC, both molecules are expressed frequently and extensively, while expression of 
these two molecules are infrequent or focal in control livers (chronic viral hepatitis 
(CVH) and extrahepatic biliary obstruction (EBO)). There is a statistical correlation in the 
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distribution of these two molecules (p<0.01, rs=0.558).  
 
3. Correlation between autophagy markers and senescent markers.  
A) Correlation between expression of LC3 and p16 in ductular reaction (DR) in primary 
biliary cirrhosis (PBC) and control diseases. In PBC, both molecules are expressed 
frequently and extensively, while expression of these two molecules are infrequent or 
focal in control livers (chronic viral hepatitis (CVH) and extrahepatic biliary obstruction 
(EBO)). There is a statistical correlation in the distribution of these two molecules 
(p<0.01, rs=0.574). 
B) Correlation between expression of LC3 and p21 in ductular reaction (DR) in primary 
biliary cirrhosis (PBC) and control diseases. In PBC, both molecules are expressed 
frequently and extensively, while expression of these two molecules are infrequent or 
focal in control livers (CVH and EBO). There is a statistical correlation in the distribution 
of these two molecules (p<0.01, rs=0.462). 
C) Correlation between expression of p62 and p16 in ductular reaction (DR) in primary 
biliary cirrhosis (PBC) and control diseases. In PBC, both molecules are expressed 
frequently and extensively, while expression of these two molecules are infrequent or 
focal in control livers (CVH and EBO). There is a statistical correlation in the distribution 
of these two molecules (p<0.01, rs=0.335). 
D) Correlation between expression of p62 and p21 in ductular reaction (DR) in primary 
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biliary cirrhosis (PBC) and control diseases. In PBC, both molecules are expressed 
frequently and extensively, while expression of these two molecules are infrequent or 
focal in control livers (CVH and EBO). There is a statistical correlation in the distribution 
of these two molecules (p<0.05, rs=0.285). 
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Abstract 
Background and Aim. Recent studies disclosed that autophagy facilitates the process of 
senescence. Given cellular senescence is involved in the pathophysiology of ductular reaction 
(DR) in primary biliary cirrhosis (PBC), we examined an involvement of autophagy in DRs in 
PBC and control livers. Methods. We examined immunohistochemically the expression of 
microtubule-associated proteins-light chain 3β (LC3) as autophagy marker, 
p62/sequestosome-1 (p62) as autophagy-related marker in bile ductular cells in livers taken 
from the patients with PBC (n=42) and control livers (n=100). The expression of senescent 
markers (p16INK4a and p21WAF1/Cip1) in bile ductular cells and their correlation with autophagy 
was also evaluated. Results. The expression of LC3 was seen in coarse vesicles in cytoplasm 
of bile ductular cells and significantly more frequent in PBC of both early and advanced 
stages, when compared with control livers (p<0.01). The expression of p62 was seen as 
intracytoplasmic aggregates and significantly more frequent in PBC, when compared with 
control livers (p<0.05). The expression of LC3 and p62 significantly correlated each other 
(p<0.01). The expression of LC3 and p62 significantly correlated with the expression of 
p16INK4a, p21WAF1/Cip1 (p<0.05). Conclusion. Autophagy is frequently seen in bile ductular 
cells in DRs in PBC. Since cellular senescence of bile ductular cells is rather frequent in the 
advanced stage of PBC, autophagy may precede cellular senescence of bile ductular cells in 
DRs in PBC. 
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Introduction 
Ductular reaction (DR) is a reactive lesion at the portal tract interface comprising increased 
bile ductules with an accompanying complex of stromal and inflammatory cells (1). The 
involvement of DR has been implicated in the pathogenesis of progressive fibrosis, 
regeneration and hepatocarcinogenesis in chronic liver disease (1-3). We have recently 
reported that bile ductular cells undergoing cellular senescence, which are characterized by 
the augmented expression of senescence-associated β-galactosidase (SA-β-gal), p16INK4a and 
p21WAF1/Cip and telomere shortening, increase in PBC along with fibrous progression, 
especially in PBC (4-6). Cellular senescence is a state of stable cell arrest with active 
metabolism and a failsafe program against a variety of cellular insults. Cellular senescence is 
a delayed stress response involving multiple effector mechanisms such as the DNA damage 
response (7) and the senescence-associated secretion phenotype (SASP)(8-11). Such 
senescent bile ductular cells may be involved in the progression of fibrosis of these diseases, 
through the secretion of SASP (4-6, 11).  
Autophagy (hereafter referred to as autophagy) in human diseases has been 
highlighted during the last decade (12-14) and recent data demonstrated that autophagy is 
significantly involved in the pathophysiology of liver diseases (15-21). Macroautophagy is a 
genetically regulated program responsible for the turnover of cellular proteins and damaged 
organelles. This evolutionarily conserved process is characterized by the formation of double 
membrane cytosolic vesicles, autophagosomes, which sequester cytoplasmic content and 
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deliver it to lysosomes (12, 13, 22, 23). Autophagy can enable adaptation to stress through the 
degradation of cellular proteins and organelles to suppress damage, maintain metabolism, and 
promote cellular viability and fitness (12-14, 23). An appropriate cellular stress response is 
critical for maintaining tissue integrity and function and for preventing diseases. Cells 
respond to stress with adaptation, repair, and recovery, or are diverted into irreversible cell 
cycle exit (senescence) or are eliminated through programmed cell death (apoptosis)(23). 
Dysfunctional autophagy appears to be associated with cellular senescence (23).  
Autophagy and cellular senescence are two distinct cellular responses to stress. 
Recent studies disclosed that autophagy facilitates the process of senescence (22). We have 
also reported that autophagy may precedes biliary epithelial senescence in the damaged bile 
ducts in primary biliary cirrhosis (PBC)(20). Although cellular senescence is involved in the 
pathophysiology of DR along with fibrous progression in primary biliary cirrhosis (PBC) 
(4-6), there has been no study reporting the involvement of autophagy in ductular cells in PD. 
In the present study, we examined an involvement of autophagy and its association with 
cellular senescence in DRs in PBC and control livers.  
 
Materials and Methods 
Classification of intrahepatic biliary tree. The intrahepatic biliary tree is classified into the 
intrahepatic large and small bile ducts (septal and interlobular bile ducts) by their size and 
distributions in the portal tracts (24). In this study, septal and interlobular bile ducts are 
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termed small bile ducts. Bile ductules are not included in the small bile ducts. Bile ductules 
are characterized by tubular or glandular structures with poorly defined lumen and located at 
the periphery of the portal tracts and are not accompanied by parallel running hepatic arterial 
branches (1, 24). Ductular cells in ductular reaction (1) including intermediate hepatobiliary 
cells with heterogeneous phenotype in the diseased liver were also evaluated 
Liver tissue preparation. A total of 142 liver tissue specimens (all were biopsied or 
surgically-resected) were collected from the liver disease file of our laboratory and affiliated 
hospitals. The liver specimens enrolled in this study were 42 PBC, 41 chronic viral hepatitis 
(CVH) livers, 27 nonalcoholic steatohepatitis (NASH), 10 extrahepatic biliary obstruction 
(EBO) livers and 22 “histologically normal” livers. All PBC were from the patients fulfilling 
the clinical, serological and histological characteristics consistent with the diagnosis of PBC 
(25). PBC livers were staged histologically (26) and 29 and 13 of PBC were of stages 1, 2 
(early PBC) and of stages 3, 4 (advanced PBC), respectively. Twenty-seven CVH were 
regarded as F0-2 and 14 as F3, 4, respectively (27). Three and 38 of CVH cases were 
serologically positive for hepatitis B surface antigen (HBsAg) and anti-hepatitis C viral 
antibody (HCVAb), respectively. The grade of activity and stage in the patients with NASH 
were assessed by using the criteria proposed by Brunt et al. (28), and 14 and 13 NASH were 
regarded as stages 1, 2 and stages 3, 4, respectively. Causes of EBO were obstruction of the 
bile duct at the hepatic hilum or the extrahepatic bile ducts, because of carcinoma or stone, 
and the duration of jaundice was less than 1 month. “Histologically normal” livers were 
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obtained from surgically resected livers for traumatic hepatic rupture or metastatic liver tumor. 
The liver tissues used were taken from the part sufficiently away from the trauma and tumor.  
Liver tissue samples were fixed in 10% neutral buffered formalin, and embedded in 
paraffin. More than twenty serial sections, 4 μm thick, were cut from each block. Several 
were processed routinely for histopathologic study, and the remainder was processed for the 
following immunohistochemistry. The Committee of Ethics in Kanazawa University 
approved this study.  
Immunohistochemistry. We examined immunohistochemically the expression of 
microtubule-associated proteins-light chain 3β (LC3) as an autophagy marker, 
p62/sequestosome-1 (p62)(29, 30) as an autophagy-related marker in bile ductular cells. The 
expression of senescent markers (p16INK4a and p21WAF1/Cip1) in bile ductular cells and their 
correlation with autophagy was also examined in same sample series. Immunostaining was 
performed using the antibodies shown in Table 1, as described previously (31). In brief, after 
pretreatment for antigen retrieval as described in Table 1, blocking endogenous peroxidase, 
the sections were incubated with the primary antibody at 4 degree overnight. The Envision+ 
solution (Dako) was then applied for 30 min at room temperature.  The reaction products 
were visualized using 3-3’-diaminobenizidine tetra hydrochloride (Sigma Chemica, Co., St. 
Louis, MO) and H2O2. The sections were then lightly counterstained with methyl green or 
hematoxylin. A similar dilution of the control mouse IgG (Dako) was applied instead of the 
                                                          Sasaki  -9- 
 
primary antibody as negative control.  Positive and negative controls were routinely 
included.  
Assessment of immunostaining. All fields of each liver specimen were observed under light 
microscope for the evaluation of immunohistochemical expression of LC3, p62, p16INK4a and 
p21WAF1/Cip1. The extent of expression was semiquantitatively evaluated as 1+ (focal, positive 
cells are detected in one third or fewer portal tracts), and 2+ (extensive, positive cells are 
detected in more than one third of portal tracts). 
 
Statistical analysis. Statistical analysis for the difference used the Wilcoxon rank sum test. 
The correlation coefficient of 2 factors was evaluated using Spearman’s rank correlation test. 
When the P value was less than 0.05, the difference was regarded as significant.   
 
Results 
LC3. The expression of LC3 was seen in coarse vesicles in the cytoplasm of bile ductular 
cells, when detectable (Fig.1A). As shown in Figure 2A, the expression of LC3 was more 
frequent in ductular cells in the early stages of PBC (1+, 50%; 2+, 15%) and the advanced 
stages of PBC (1+, 23%; 2+, 31%), compared to other groups; CVH, F1/2 (1+, 6.7%; 2+, 0%), 
CVH, F3/4 (1+, 18%; 2+, 0%), NASH stages 1 and 2 (1+, 0%; 2+, 0%), NASH stages 3 and 4 
(1+, 8.3%; 2+, 0%), EBO (1+, 10%; 2+, 0%) and normal livers (1+, 0%; 2+, 0%), respectively 
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(p<0.01). The expression of LC3 in CVH, F3/4 was significantly more frequent, compared to 
normal livers (p<0.05).   
p62. The expression of p62 was seen as intracytoplasmic aggregates in bile ductular cells, 
when detectable (Fig.1B). As shown in Figure 2B, the expression of p62 was more frequent in 
ductular cells in the early stages of PBC (1+, 45%; 2+, 17%) and the advanced stages of PBC 
(1+, 31%; 2+, 31v%), compared to NASH stages 1 and 2 (1+, 0%; 2+, 0%) and normal livers 
(1+, 9%; 2+, 0%), respectively (p<0.01). The expression of p62 was more frequent in the 
early and advanced stages of PBC, compared to CVH, F1/2 (1+, 33%; 2+, 0%), CVH, F3/4 
(1+, 14%; 2+, 7.1%), respectively (p<0.05).  
The correlation between expressions of LC3, p62, p16INK4a and p21WAF1/Cip1.  
The expression of LC3 and p62 (p<0.01, rs=0.38703) were significantly correlated in bile 
ductular cells (Fig.2C). The expression of p16INK4a and p21WAF1/Cip1 were significantly more 
frequent in bile ductular cells in PBC, stage 3, 4, when compared with control livers (p<0.05), 
as previously reported (5, 6). There were significant correlation between the expression of 
LC3 and p16INK4a (p<0.01, rs=0.574), the expression of LC3 and p21WAF1/Cip1 (p<0.01, 
rs=0.462), the expression of p62 and p16INK4a (p<0.01, rs=0.336), the expression of p62 and 
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Discussion 
The data obtained in this study are summarized as follows; 1) LC3, an autophagy marker, and 
p62, an autophagy-related marker, were frequently expressed in ductular cells in DR in PBC, 
compared to those in CVH, NASH, EBO and normal livers. 2) The expression of LC3 and 
p62 was significantly correlated each other in ductular cells in DR. 3) The expression of LC3 
and p62 was significantly correlated with the expression of senescent markers: p16INK4a and 
p21WAF1/Cip1 in ductular cells in DR. 
The present study firstly disclosed that ductular cells in DR frequently show 
autophagy detected by immunostaining for LC3 in PBC, whereas autophagy is infrequently 
detected in DR in control livers. This finding clearly indicates that autophagy is involved in 
the pathogenesis of DR in PBC and DR in PBC may be different from other liver disease. We 
have shown that autophagy is upregulated in the damage bile ducts in PBC (20). Therefore, 
the autophagy appears to be a common feature of biliary epithelial cells in small bile ducts 
and DR in PBC. 
Furthermore, it is of interest that the accumulation of p62 is frequently seen in DR 
in PBC, similarly to LC3. p62 is an adaptor protein involved in the delivery of 
ubiquitin-bound cargo to the autophagosome and regulates the formation of protein 
aggregates (29, 32-34). An accumulation of p62 is seen in autphagy-deficient condition, so, 
the accumulation of p62 may be a marker of dysfunctional autophagy in which the capacity of 
autophagy is not much enough to process the damaged proteins bound to p62(19, 21, 35). 
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Therefore, the accumulation of p62 may reflect dysfunctional autophagy in ductular cells in 
DR in PBC. In addition, the expression of LC3 and p62 was significantly correlated each 
other in ductular cells in DR. Taken together, autophagy, especially dysfunctional autophagy 
may be involved in the pathophysiology of ductular cells in PBC. 
Recent studies have disclosed that autophagy preceded and accelerated cellular 
senescence (22) and we have also reported that autophagy mediates biliary epithelial 
senescence (20). Our previous study shows that some of ductular cells in DR in chronic liver 
diseases were at G1- arrest and undergoing cellular senescence and that such senescent cells 
may be involved in the progression of fibrosis of these diseases, particularly in PBC (6). The 
present study revealed that the expression of autophagy markers: LC3 and p62 was 
significantly correlated with the expression of senescent markers: p16INK4a and p21WAF1/Cip1 in 
ductular cells in DR. This finding suggests that autophagy is involved in the biliary epithelial 
senescence in DR. Dysfunctional autphagy may induce cellular senescence. It is of interest 
that autophagy is upregulated in DR in both early and advanced PBC, whereas cellular 
senescence is more frequent in DR in the advanced PBC in our previous study. This may also 
support hypothesis that biliary epithelial senescence may be induced via process of autophagy. 
Taken together, the regulation of autophagy may be a therapeutic target to prevent the 
progression of fibrosis along with biliary epithelial senescence in PBC. 
In conclusion, autophagy is frequently seen and correlated with cellular senescene 
in bile ductular cells in DRs in PBC, both in the early and advanced stage. These findings 
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suggest that autophagy may be involved in the pathophysiology of DRs in PBC and may 
precede cellular senescence of bile ductular cells in DRs in PBC. Since cellular senescence of 
bile ductular cells is rather frequent in the adanced stage of PBC, autophagy may precede 
cellular senescence of bile ductular cells in DRs in PBC.  
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Figure legends 
1. Expression of LC3 and p62 in ductular reaction (DR) in PBC and control liver.  
A) Coarse vesicular expression of LC3 in DRs in PBC. Coarse vesicular expression of LC3 is 
seen in the cytoplasm of ductular cells in PBC (left, arrows), whereas no expression of LC3 is 
found in ductular cells in CVH, C (right, arrows). Immunostaining for LC3. Original 
magnification, x400. B) Coarse vesicular expression of p62 is seen in the cytoplasm of 
ductular cells in PBC (left, arrows), whereas no or faint expression of p62 is found in ductular 
cells in CVH, C (right, arrows). Immunostaining for p62. Original magnification, x400.  
 
2. Increased expression of LC3 and p62 in ductular reaction (DR) in PBC. 
A) The frequency and extent of LC3 expression. White column, focal expression (1+), 
gray columns, extensive expression (2+). a, p<0.01 vs other groups, b, p<0.05 vs normal 
liver (NL). B) The frequency and extent of p62 expression. White column, focal 
expression (1+), gray columns, extensive expression (2+). a, p<0.01 vs normal liver (NL) 
and nonalcoholic steatohepatitis (NASH), stage (st)1 and 2, b, p<0.05 vs chronic viral 
hepatitis (CVH), F1 and F2 and F3 and F4. C) Correlation between expression of LC3 
and p62 in ductular reaction (DR) in primary biliary cirrhosis (PBC) and control diseases. 
In PBC, both molecules are expressed frequently and extensively, while expression of 
these two molecules are infrequent or focal in control livers (chronic viral hepatitis 
(CVH) and extrahepatic biliary obstruction (EBO)). There is a statistical correlation in the 
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distribution of these two molecules (p<0.01, rs=0.558).  
 
3. Correlation between autophagy markers and senescent markers.  
A) Correlation between expression of LC3 and p16 in ductular reaction (DR) in primary 
biliary cirrhosis (PBC) and control diseases. In PBC, both molecules are expressed 
frequently and extensively, while expression of these two molecules are infrequent or 
focal in control livers (chronic viral hepatitis (CVH) and extrahepatic biliary obstruction 
(EBO)). There is a statistical correlation in the distribution of these two molecules 
(p<0.01, rs=0.574). 
B) Correlation between expression of LC3 and p21 in ductular reaction (DR) in primary 
biliary cirrhosis (PBC) and control diseases. In PBC, both molecules are expressed 
frequently and extensively, while expression of these two molecules are infrequent or 
focal in control livers (CVH and EBO). There is a statistical correlation in the distribution 
of these two molecules (p<0.01, rs=0.462). 
C) Correlation between expression of p62 and p16 in ductular reaction (DR) in primary 
biliary cirrhosis (PBC) and control diseases. In PBC, both molecules are expressed 
frequently and extensively, while expression of these two molecules are infrequent or 
focal in control livers (CVH and EBO). There is a statistical correlation in the distribution 
of these two molecules (p<0.01, rs=0.335). 
D) Correlation between expression of p62 and p21 in ductular reaction (DR) in primary 
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biliary cirrhosis (PBC) and control diseases. In PBC, both molecules are expressed 
frequently and extensively, while expression of these two molecules are infrequent or 
focal in control livers (CVH and EBO). There is a statistical correlation in the distribution 
of these two molecules (p<0.05, rs=0.285). 
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Table 1. Primary antibodies used in this study. 
 
Primary antibody Type (clone) Pre-treatment dilution Source 
  LC3 Goat poly MW-CB (95℃, 20min) 1:50 Santa-Cruz, Santa-Cruz, CA 
  p62 Rabbit poly eARI –BA (121℃, 5min) 1:1000 MBL, Nagoya, Japan 
  p16INK4a Mouse mono (JC8) eARI –BA (121℃, 5min) 1:100 Neomarkers, Freemont, CA 
  p21WAF1/Cip1 Mouse mono (70) eARI –BA (121℃, 5min) 1:100 BD Transduction, San Jose, CA 
p62, p62/sequestosome-1; LC3, microtubule-associated proteins-light chain 3; LAMP-1, lysosome-associated membrane protein-1; 
MW, microwave treatment; CB, 0.05M citric buffer (pH 6); eARI, electronic antigen retrieval instrument (pascal, Dako); BA, 0.05M 
boric acid buffer (pH 8).  
 
